First Time Loading...

Paion AG
XETRA:PA8

Watchlist Manager
Paion AG Logo
Paion AG
XETRA:PA8
Watchlist
Price: 0.25 EUR -30.56% Market Closed
Updated: May 5, 2024

Wall Street
Price Targets

PA8 Price Targets Summary
Paion AG

There are no price targets for PA8.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Paion AG Competitors:
Price Targets
MAB
Mabion SA
3% Downside
VCEL
Vericel Corp
15% Upside
PHM
Pharma Mar SA
70% Upside
IMCR
Immunocore Holdings PLC
44% Upside
ALGEN
Genoway SA
62% Upside
MGNX
MacroGenics Inc
61% Upside
DCPH
Deciphera Pharmaceuticals Inc
6% Upside
600201
Jinyu Bio-Technology Co Ltd
5% Upside

Revenue
Forecast

Revenue Estimate
Paion AG

For the last 1 year the compound annual growth rate for Paion AG's revenue is 366%. The projected CAGR for the next 2 years is -19%.

366%
Past Growth
-19%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Paion AG

Operating Income forecast
is not available for
Paion AG

Net Income
Forecast

Net Income Estimate
Paion AG

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PA8's stock price target?
Not Available

PA8 doesn't have any price targets made by Wall Street professionals.

What is Paion AG's Revenue forecast?
Projected CAGR
-19%

For the last 1 year the compound annual growth rate for Paion AG's revenue is 366%. The projected CAGR for the next 2 years is -19%.